Acantholysis

Acantholysis is a pathological condition characterized by the loss of cohesion between keratinocytes, the predominant cell type in the epidermis. This process leads to the breakdown of the epidermal structure, resulting in the formation of blisters and erosions on the skin and mucous membranes.

Pathophysiology

Acantholysis occurs due to the disruption of desmosomes, which are specialized structures that facilitate cell-to-cell adhesion in the epidermis. The loss of desmosomal function can be caused by various factors, including autoimmune diseases, genetic mutations, and infections. The detachment of keratinocytes leads to the formation of intraepidermal clefts and vesicles.

Causes

Acantholysis can be seen in several dermatological conditions, including:

• Pemphigus vulgaris: An autoimmune disease where autoantibodies target desmogleins, components of desmosomes.
• Pemphigus foliaceus: Another autoimmune condition affecting desmogleins, but typically less severe than pemphigus vulgaris.
• Hailey-Hailey disease: A genetic disorder caused by mutations in the ATP2C1 gene, leading to defective calcium transport and impaired desmosomal function.
• Darier's disease: A genetic condition resulting from mutations in the ATP2A2 gene, affecting calcium homeostasis and desmosomal integrity.
• Herpes simplex virus infection: The virus can cause acantholysis by directly infecting keratinocytes and disrupting their adhesion.

Clinical Presentation

Patients with acantholysis may present with:

• Blisters: Fluid-filled lesions that can rupture, leading to erosions.
• Erosions: Areas where the epidermis has been lost, exposing the underlying dermis.
• Crusting: Formation of dried exudate on the skin surface.
• Pruritus: Itching, which may accompany the lesions.

Diagnosis

The diagnosis of acantholysis is typically made through:

• Clinical examination: Observation of characteristic skin lesions.
• Skin biopsy: Histopathological examination revealing loss of keratinocyte cohesion and intraepidermal clefting.
• Direct immunofluorescence: Detection of autoantibodies in autoimmune conditions like pemphigus vulgaris.

Treatment

The treatment of acantholysis depends on the underlying cause:

• Corticosteroids: Used to reduce inflammation and immune response in autoimmune conditions.
• Immunosuppressive agents: Such as azathioprine or mycophenolate mofetil for severe autoimmune cases.
• Antiviral medications: For acantholysis caused by herpes simplex virus infection.
• Topical treatments: Including antibiotics and emollients to manage secondary infections and maintain skin hydration.

Prognosis

The prognosis of acantholysis varies depending on the underlying condition and the effectiveness of treatment. Autoimmune conditions like pemphigus vulgaris can be chronic and require long-term management, while infections may resolve with appropriate antiviral therapy.

See Also

• Epidermis
• Keratinocyte
• Desmosome
• Blister
• Autoimmune disease

References

‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian